• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Annual Changes to the Nasdaq-100 Index

    12/11/20 8:05:00 PM ET
    $TTWO
    $TEAM
    $AEP
    $PTON
    Services-Misc. Amusement & Recreation
    Consumer Discretionary
    Computer Software: Prepackaged Software
    Technology
    Get the next $TTWO alert in real time by email

    NEW YORK, Dec. 11, 2020 (GLOBE NEWSWIRE) -- Nasdaq (Nasdaq: NDAQ) today announced the results of the annual reconstitution of the Nasdaq-100 Index® (Nasdaq: NDX), which will become effective prior to market open on Monday, December 21, 2020.

    The following six companies will be added to the Index: American Electric Power Company, Inc. (Nasdaq: AEP), Marvell Technology Group Ltd. (Nasdaq: MRVL), Match Group, Inc. (Nasdaq: MTCH), Okta, Inc. (Nasdaq: OKTA), Peloton Interactive, Inc. (Nasdaq: PTON), Atlassian Corporation Plc (Nasdaq: TEAM).

    The Nasdaq-100 Index is composed of the 100 largest non-financial companies listed on The Nasdaq Stock Market® and dates to January 1985 when it was launched along with the Nasdaq Financial-100 Index®, which is comprised of the 100 largest financial stocks on Nasdaq®. These indexes act as benchmarks for financial products such as options, futures, and funds. The Nasdaq-100 is reconstituted each year in December, timed to coincide with the quadruple witch expiration Friday of the quarter.

    The Nasdaq-100 Index is the basis of the Invesco QQQ Trust (Nasdaq: QQQ) which aims to provide investment results that, before expenses, correspond with the Nasdaq-100 Index performance. In addition, options, futures and structured products based on the Nasdaq-100 Index and the Invesco QQQ Trust trade on various exchanges.

    As a result of the reconstitution, the following six companies will be removed from the Index: BioMarin Pharmaceutical Inc. (Nasdaq: BMRN), Citrix Systems, Inc. (Nasdaq: CTXS), Expedia Group, Inc. (Nasdaq: EXPE), Liberty Global plc (Nasdaq: LBTYA/LBTYK), Take-Two Interactive Software, Inc. (Nasdaq: TTWO), Ulta Beauty, Inc. (Nasdaq: ULTA).

    Information
    For information about the six companies to be added to the Nasdaq-100 Index, please visit the following respective company websites:

    American Electric Power Company, Inc. – https://www.aep.com/

    Marvell Technology Group Ltd. – https://www.marvell.com/

    Match Group, Inc. – https://www.mtch.com/

    Okta, Inc. – https://www.okta.com/

    Peloton Interactive, Inc. – https://www.onepeloton.com/

    Atlassian Corporation Plc – https://www.atlassian.com/

    About Nasdaq Global Indexes
    Nasdaq Global Indexes has been creating innovative, market-leading, transparent indexes since 1971. Today, our index offering spans geographies and asset classes and includes diverse families such as the Dividend and Income (includes Dividend Achievers), Dorsey Wright, Fixed Income (includes BulletShares®), Global Equity, Green Economy, Nordic and Commodity indexes. We continuously offer new opportunities for financial product sponsors across a wide-spectrum of investable products and for asset managers to measure risk and performance. Nasdaq also provides exchange listing, custom index and design solutions to financial organizations worldwide.

    About Nasdaq
    Nasdaq (Nasdaq: NDAQ) is a global technology company serving the capital markets and other industries. Our diverse offering of data, analytics, software and services enables clients to optimize and execute their business vision with confidence. To learn more about the company, technology solutions and career opportunities, visit us on LinkedIn, on Twitter @Nasdaq, or at www.nasdaq.com.

    Media Relations Contact
    Emily Pan
    (646) 637-3964
    [email protected]

    Issuer & Investor Contact
    Index Client Services
    [email protected]

    The information contained above is provided for informational and educational purposes only, and nothing contained herein should be construed as investment advice, either on behalf of a particular financial product or an overall investment strategy. Neither Nasdaq, Inc. nor any of its affiliates makes any recommendation to buy or sell any financial product or any representation about the financial condition of any company or fund. Statements regarding Nasdaq’s proprietary indexes are not guarantees of future performance. Actual results may differ materially from those expressed or implied. Past performance is not indicative of future results. Investors should undertake their own due diligence and carefully evaluate companies before investing. ADVICE FROM A SECURITIES PROFESSIONAL IS STRONGLY ADVISED.

    -NDAQG-


    Get the next $TTWO alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $TTWO
    $TEAM
    $AEP
    $PTON

    CompanyDatePrice TargetRatingAnalyst
    American Electric Power Company Inc.
    $AEP
    2/27/2026$132.00Sell → Neutral
    UBS
    Nasdaq Inc.
    $NDAQ
    2/26/2026$106.00Hold → Buy
    TD Cowen
    Okta Inc.
    $OKTA
    2/26/2026$90.00 → $83.00Market Perform
    BMO Capital Markets
    Ulta Beauty Inc.
    $ULTA
    2/20/2026$647.00 → $800.00Strong Buy
    Raymond James
    American Electric Power Company Inc.
    $AEP
    2/13/2026$142.00Peer Perform → Outperform
    Wolfe Research
    Take-Two Interactive Software Inc.
    $TTWO
    2/10/2026$285.00Outperform → Strong Buy
    Raymond James
    Peloton Interactive Inc.
    $PTON
    2/10/2026Buy → Hold
    Argus
    Atlassian Corporation
    $TEAM
    2/6/2026$135.00 → $130.00Outperform
    BMO Capital Markets
    More analyst ratings

    $TTWO
    $TEAM
    $AEP
    $PTON
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    American Electric upgraded by UBS with a new price target

    UBS upgraded American Electric from Sell to Neutral and set a new price target of $132.00

    2/27/26 8:19:46 AM ET
    $AEP
    Electric Utilities: Central
    Utilities

    NASDAQ upgraded by TD Cowen with a new price target

    TD Cowen upgraded NASDAQ from Hold to Buy and set a new price target of $106.00

    2/26/26 7:10:22 AM ET
    $NDAQ
    Investment Bankers/Brokers/Service
    Finance

    BMO Capital Markets reiterated coverage on Okta with a new price target

    BMO Capital Markets reiterated coverage of Okta with a rating of Market Perform and set a new price target of $83.00 from $90.00 previously

    2/26/26 6:48:00 AM ET
    $OKTA
    Computer Software: Prepackaged Software
    Technology

    $TTWO
    $TEAM
    $AEP
    $PTON
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    U.S. Food and Drug Administration Approves BioMarin's PALYNZIQ® (pegvaliase-pqpz) for Adolescents 12 Years of Age and Older with Phenylketonuria (PKU)

    Treatment with PALYNZIQ led to statistically significant blood phenylalanine (Phe) lowering compared to diet alone in pivotal Phase 3 PEGASUS studyPALYNZIQ is the only enzyme substitution therapy approved for the treatment of people with PKUSAN RAFAEL, Calif., Feb. 27, 2026 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) today announced that the U.S. Food and Drug Administration (FDA) has approved the company's supplemental Biologics License Application (sBLA) for PALYNZIQ® (pegvaliase-pqpz) to include pediatric patients 12 years of age and older with phenylketonuria (PKU). PALYNZIQ is the only enzyme substitution therapy approved to reduce blood phenylalanine (Phe) concentrations

    2/27/26 8:00:00 PM ET
    $BMRN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Nasdaq Executives to Present at Upcoming Investor Conferences

    NEW YORK, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Nasdaq (NASDAQ:NDAQ) will be presenting at the following conferences in March with webcasts available at Nasdaq's Investor Relations website: https://ir.nasdaq.com/. Who:Sarah Youngwood, Executive Vice President & Chief Financial Officer, NasdaqWhat:Morgan Stanley Technology, Media & Telecom ConferenceWhen:Monday, March 2nd, 11:30 AM ET  Who:Jeremy Skule, Executive Vice President, Chief Strategy Officer & Executive Chair, Financial Crime Management Technology, NasdaqWhat:Raymond James 47thAnnual Institutional Investors ConferenceWhen:Wednesday, March 4th, 8:05 AM ET   About NasdaqNasdaq (NASDAQ:NDAQ) is a leading technology platform that powers t

    2/26/26 5:00:00 PM ET
    $NDAQ
    Investment Bankers/Brokers/Service
    Finance

    Tinder to Host First-Ever Product Event

    LOS ANGELES, Feb. 26, 2026 /PRNewswire/ -- Match Group (NASDAQ:MTCH) today announced that Tinder will host its first-ever product event, SPARKS 2026: Start Something New, to showcase upcoming feature updates and a deeper look into its roadmap. The event, which will include keynote presentations from Tinder executives, will be held on Thursday, March 12th at 2:00 p.m. Eastern Time (ET). A live webcast will be available at https://ir.mtch.com/investor-relations/news-events/events-archive/.About Match GroupMatch Group (NASDAQ:MTCH), through its portfolio companies, is a leading pro

    2/26/26 4:05:00 PM ET
    $MTCH
    Computer Software: Programming Data Processing
    Technology

    $TTWO
    $TEAM
    $AEP
    $PTON
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    June 29, 2023 - FDA Approves First Gene Therapy for Adults with Severe Hemophilia A

    For Immediate Release: June 29, 2023 Today, the U.S. Food and Drug Administration approved Roctavian, an adeno-associated virus vector-based gene therapy for the treatment of adults with severe hemophilia A without pre-existing antibodies to adeno-associated virus serotype 5 detected by an FDA-approved test. “Hereditary hemophilia A is a potentially serious bleeding disorder. Severe cases of hemophilia A can ca

    6/29/23 6:02:12 PM ET
    $BMRN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $TTWO
    $TEAM
    $AEP
    $PTON
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Torgeby Johan bought $958,320 worth of shares (12,000 units at $79.86), increasing direct ownership by 42% to 40,797 units (SEC Form 4)

    4 - NASDAQ, INC. (0001120193) (Issuer)

    2/19/26 4:00:18 PM ET
    $NDAQ
    Investment Bankers/Brokers/Service
    Finance

    Large owner Investor Ab bought $15,835,040 worth of shares (200,000 units at $79.18) (SEC Form 4)

    4 - NASDAQ, INC. (0001120193) (Issuer)

    2/13/26 3:56:39 PM ET
    $NDAQ
    Investment Bankers/Brokers/Service
    Finance

    Chief Executive Officer Rascoff Spencer M bought $445,691 worth of shares (14,000 units at $31.84), increasing direct ownership by 9% to 165,128 units (SEC Form 4)

    4 - Match Group, Inc. (0000891103) (Issuer)

    11/20/25 4:15:48 PM ET
    $MTCH
    Computer Software: Programming Data Processing
    Technology

    $TTWO
    $TEAM
    $AEP
    $PTON
    SEC Filings

    View All

    SEC Form S-3ASR filed by Match Group Inc.

    S-3ASR - Match Group, Inc. (0000891103) (Filer)

    2/26/26 5:18:51 PM ET
    $MTCH
    Computer Software: Programming Data Processing
    Technology

    SEC Form 10-K filed by Match Group Inc.

    10-K - Match Group, Inc. (0000891103) (Filer)

    2/26/26 4:51:17 PM ET
    $MTCH
    Computer Software: Programming Data Processing
    Technology

    SEC Form 144 filed by Take-Two Interactive Software Inc.

    144 - TAKE TWO INTERACTIVE SOFTWARE INC (0000946581) (Subject)

    2/26/26 12:52:12 PM ET
    $TTWO
    Services-Misc. Amusement & Recreation
    Consumer Discretionary

    $TTWO
    $TEAM
    $AEP
    $PTON
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Financial Officer Tighe Brett was granted 64,798 shares, increasing direct ownership by 48% to 199,183 units (SEC Form 4)

    4 - Okta, Inc. (0001660134) (Issuer)

    2/27/26 5:25:38 PM ET
    $OKTA
    Computer Software: Prepackaged Software
    Technology

    Officer Schwartz Larissa was granted 44,930 shares, increasing direct ownership by 124% to 81,258 units (SEC Form 4)

    4 - Okta, Inc. (0001660134) (Issuer)

    2/27/26 5:24:38 PM ET
    $OKTA
    Computer Software: Prepackaged Software
    Technology

    Chief Accounting Officer Ninan Shibu was granted 8,390 shares, increasing direct ownership by 48% to 25,858 units (SEC Form 4)

    4 - Okta, Inc. (0001660134) (Issuer)

    2/27/26 5:23:37 PM ET
    $OKTA
    Computer Software: Prepackaged Software
    Technology

    $TTWO
    $TEAM
    $AEP
    $PTON
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Atlassian Corporation

    SC 13G/A - Atlassian Corp (0001650372) (Subject)

    11/14/24 1:22:40 PM ET
    $TEAM
    Computer Software: Prepackaged Software
    Technology

    Amendment: SEC Form SC 13G/A filed by Peloton Interactive Inc.

    SC 13G/A - PELOTON INTERACTIVE, INC. (0001639825) (Subject)

    11/14/24 1:22:39 PM ET
    $PTON
    Recreational Games/Products/Toys
    Consumer Discretionary

    Amendment: SEC Form SC 13G/A filed by Peloton Interactive Inc.

    SC 13G/A - PELOTON INTERACTIVE, INC. (0001639825) (Subject)

    11/13/24 12:52:42 PM ET
    $PTON
    Recreational Games/Products/Toys
    Consumer Discretionary

    $TTWO
    $TEAM
    $AEP
    $PTON
    Leadership Updates

    Live Leadership Updates

    View All

    Atlassian Appoints James Chuong as Chief Financial Officer

    Atlassian Corporation (NASDAQ:TEAM), a leading provider of team collaboration and productivity software, today announced the appointment of James Chuong as Chief Financial Officer (CFO), effective March 30, 2026. As CFO, James will oversee Atlassian's Finance and Legal teams, bringing more than 20 years of finance leadership experience across the technology and investment banking sectors. Most recently, James served as Chief Financial Officer at LinkedIn, where he led the company's financial operations and helped guide it to more than 1 billion members and $18 billion in revenue. During his 13 years at LinkedIn, he held several finance leadership roles, leading global teams responsible

    2/18/26 5:15:00 PM ET
    $TEAM
    Computer Software: Prepackaged Software
    Technology

    Match Group Announces Manuel Bronstein and Raina Moskowitz to Join Board of Directors

    LOS ANGELES, Feb. 17, 2026 /PRNewswire/ -- Match Group (NASDAQ:MTCH) announced today that seasoned technology executives Manuel Bronstein and Raina Moskowitz are expected to join the Company's Board of Directors in connection with the 2026 Annual Meeting of Stockholders. Bronstein and Moskowitz were identified through a deliberate and thorough search process. "As we continue to strengthen the skills and expertise represented on our Board to support Match Group's growth and success, I am pleased to welcome Raina and Manuel and look forward to their insights and contributions," sa

    2/17/26 9:20:00 AM ET
    $MTCH
    Computer Software: Programming Data Processing
    Technology

    PALMETTO APPOINTS LIZ CODDINGTON AS CHIEF FINANCIAL OFFICER

    Peloton CFO brings deep experience scaling consumer and technology-driven businesses to expand access to affordable, reliable energy CHARLOTTE, N.C., Feb. 5, 2026 /PRNewswire/ -- Palmetto, America's leading consumer energy platform, today announced the appointment of Liz Coddington as Chief Financial Officer, effective March 30th, 2026. Coddington will join Palmetto at the close of her four-year tenure as Chief Financial Officer of Peloton Interactive, Inc. (NASDAQ:PTON), where she is currently leading the company's global finance organization during a pivotal period of tran

    2/5/26 8:47:00 AM ET
    $PTON
    Recreational Games/Products/Toys
    Consumer Discretionary

    $TTWO
    $TEAM
    $AEP
    $PTON
    Financials

    Live finance-specific insights

    View All

    Ulta Beauty to Report Fourth Quarter and Fiscal 2025 Results on March 12, 2026

    Ulta Beauty, Inc. (NASDAQ:ULTA) today announced that its financial results for the fourth quarter and fiscal year 2025 will be released Thursday, March 12, 2026, after the market closes. The Company will host a webcast and conference call at 4:30 p.m. ET / 3:30 p.m. CT to discuss the financial results. Information about Ulta Beauty's financial results, including a link to the live webcast, will be available on the Company's Investor Relations website at https://www.ulta.com/investor. There will also be an archived webcast available for a limited time thereafter. Please register for the live event at https://q4-2025-ulta-beauty-earnings-conference-call.open-exchange.net/. About Ulta Be

    2/26/26 4:05:00 PM ET
    $ULTA
    Other Specialty Stores
    Consumer Discretionary

    BioMarin Reports Fourth Quarter and Full-year 2025 Financial and Operating Results

    Full-year 2025 Total Revenues Increased 13% Y/Y to $3.2 Billion, Led by 9% Revenue Growth for Enzyme Therapies and 26% Revenue Growth for VOXZOGO®Fourth Quarter 2025 Total Revenues Increased 17% Y/Y Led by 13% Revenue Growth for Enzyme Therapies and 31% Revenue Growth for VOXZOGOAnnounced Definitive Agreement to Acquire Amicus Therapeutics, including Galafold® for Fabry Disease and Pombiliti® + Opfolda® for Pompe Disease; Expected to Significantly Accelerate and Diversify RevenuesBioMarin Provides 2026 Guidance Excluding any Post-Close Contribution from the Announced Acquisition of Amicus, Anticipated to Close in Q2'26Conference Call and Webcast Scheduled Today at 4:30 p.m. ETSAN RAFAEL, Cal

    2/23/26 4:05:00 PM ET
    $BMRN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    BioMarin to Host Fourth Quarter and Full-Year 2025 Financial Results Conference Call and Webcast on Monday, February 23, 2026, at 4:30pm ET

    SAN RAFAEL, Calif., Feb. 17, 2026 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) today announced that Alexander Hardy, President and Chief Executive Officer of BioMarin, will host a conference call and webcast on Monday, February 23, 2026, at 4:30 p.m. ET to discuss fourth quarter and full-year 2025 financial results and provide a general business update. Dial-in Number U.S. / Canada Dial-in Number: 800-715-9871International Dial-in Number: 646-307-1963Conference Call ID: 4503000  U.S. / Canada Replay Dial-in Number: 800-770-2030International Replay Dial-in Number: 6

    2/17/26 9:00:00 AM ET
    $BMRN
    Biotechnology: Pharmaceutical Preparations
    Health Care